Imidazole → HCID 178481629, 화합물

HRID 1507054

반응식

HRID 1507054 반응식
[CH3:1][N:2]1[C:6](=[O:7])[C:5](=O)[NH:4][C:3]1=[O:9].N1C=CN=C1.C(N(CC)CC)C.Cl[Si](C)(C)C.[CH2:27]([NH2:34])[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=1>C(Cl)(Cl)Cl.O>[CH2:27]([NH:34][C:5]1[C:6](=[O:7])[N:2]([CH3:1])[C:3](=[O:9])[N:4]=1)[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=1

참가 물질

8

실험 절차

To a solution of 1-methyl-imidazolidine-2,4,5-trione (Example 1.3, Part A) (800 mg, 6.25 mmol), imidazole (467 mg, 6.87 mmol), N,N-dimethylaminopyridine (cat.) and triethylamine (1.82 mL, 13.1 mmol) in chloroform (13 mL) was added chlorotrimethylsilane (1.67 mL, 13.1 mmol) dropwise at room temperature under a nitrogen atmosphere, and the reaction mixture was stirred for 2 h. Benzylamine (0.75 mL, 6.87 mmol) was added and the reaction mixture was stirred for a further 22.5 h. The reaction mixture was diluted with chloroform and water and the chloroform extracts were dried and evaporated. The crude product was purified by column chromatography (PS with gradient elution to DCM:EtOAc 3:1) to give the product as a colourless solid (838 mg, 62%), mp 152-154° C. δH (300 MHz, CD3CN) 7.95 (v br s, 1H, NH), 7.41-7.27 (m, 5H, PhH), 4.64 (s, 2H, CH2), 2.95 (s, 3M, CH3). Mass spectrum (ESI) m/z 218 (M+H).

후처리

  1. stirringthe reaction mixture was stirred for a further 22.5 h
  2. dry with materialthe chloroform extracts were dried
  3. customevaporated
  4. customThe crude product was purified by column chromatography (PS with gradient elution to DCM:EtOAc 3:1)

출처 및 근거

ORD 기록
ord-82fa9de6dd494da5901287e5a16c3745
출처 데이터셋
uspto-grants-2015_12
특허 번호
US09221799B2

연결된 노트

불러오는 중…